Renal Cancer - Results from #5540

Study Of The Kidney Tumor-Parenchymal Interface After Neoadjuvant Treatment With Axitinib For Locally Advanced Clear Cell Renal Cell Carcinoma: Matched Analysis From A Phase II Trial October 6, 2016

When to perform preoperative chest computed tomography for renal cancer staging October 5, 2016

The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis October 5, 2016

Tumour suppressor gene (CDKNA2) status on chromosome 9p in resected renal tissue improves prognosis of localised kidney cancer October 5, 2016

Potential role of gene-environment interactions in ion transport mechanisms in the etiology of renal cell cancer October 4, 2016

Morphologic, Molecular, and Taxonomic Evolution of Renal Cell Carcinoma: A Conceptual Perspective With Emphasis on Updates to the 2016 World Health Organization Classification October 4, 2016

Renal cell carcinoma risk and obesity: A dose-response meta-analysis reveals another potential paradox within a paradox October 4, 2016

Improving needle biopsy accuracy in small renal mass using tumor-specific DNA methylation markers October 3, 2016

Effect of delayed resection after initial surveillance and tumor growth rate on final surgical pathology in patients with small renal masses (SRMs) October 3, 2016

Evaluation of beta-blockers and survival among hypertensive patients with renal cell carcinoma October 3, 2016

[Effect of Sunitinib therapy on immune function of patients with advanced renal cell carcinoma] October 3, 2016

Knockdown of serine-arginine protein kinase 1 inhibits the growth and migration in 6 renal cell carcinoma cells September 30, 2016

Sunitinib: the antiangiogenic effects and beyond September 30, 2016

Lymph Node Dissection Is Not Associated with Improved Survival Among Patients Undergoing Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: A Propensity-Score Based Analysis September 29, 2016

Eosinophil percentage elevation as a prognostic factor for overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor September 29, 2016

Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy September 28, 2016

Renal Cell Carcinoma Metastasized to Pagetic Bone September 28, 2016

Systematic review of renal carcinoma prognostic factors September 28, 2016

How Did We Obtain Complete Remission in Patients Who Had Metastatic Renal Cancer in the Era of Targeted Therapies? September 27, 2016

Improvement in survival end points of patients with metastatic renal cell carcinoma through sequential targeted therapy September 26, 2016

Page 278 of 457